News | November 10, 2021
Strides Pharma Science incurs Rs 162.55 cr. loss in Q2FY22
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
The new facility will provide an important boost to vaccine capacity in Africa
The Lucent 3D Lumbar Interbody System features a functionally unique multi-component device manufactured in a 3D printing sequence
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
Expertise in exosomes isolation and characterization will drive innovation in this field
The company is a medical dictation solution used by medical practitioners
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
_256_384.jpg)
Both parties are expected to invest a total of US $ 1 million to establish the brand
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
Subscribe To Our Newsletter & Stay Updated
